Companies who may qualify as “producers” under the EPR packaging programs adopted by California, Oregon, and Colorado should plan for sufficient lead time to evaluate their status as a producer before applicable requirements...more
Maine has once again amended and clarified its statutory restrictions on the sale of numerous categories of PFAS-containing products. The net effect of the legislation, enacted on April 16, 2024, is to 1) limit the scope and...more
This week, U.S. Senators Marco Rubio, Rick Scott, and Tom Cotton (as well as Congress member Elise Stefanik, who introduced parallel legislation) introduced the Countering CCP Drones Act in an effort to add DJI, a Chinese...more
The European Commission announced on 22 January 2020 that it is looking for feedback on draft guidelines on the implementation of Article 4 of the Market Surveillance Regulation (EU) 2019/1020 (the "Regulation"). ...more
With the EU Chemical Agency's recent announcement that four new substances will be added to the Candidate List1, you might be thinking: what's next for the UK and its chemicals legislation?...more
PFAS are currently the subject of significant regulatory action, research, litigation, and public debate based on recent reports which claim that two PFAS, Perfluorooctanoic Acid (“PFOA”) and Perfluorooctane Sulfonate...more
On July 24, the World Trade Organization (WTO) announced that 54 WTO members had reached a tentative agreement to expand the scope of the Information Technology Agreement (ITA) by adding 201 products, including new-generation...more
The Final Rule implementing the Physician Payment Sunshine Act was announced on February 1st and published in the Federal Register on February 8th. The Final Rule establishes procedures for drug and device manufacturers to...more
On Friday, February 1, 2013, the Centers for Medicare & Medicaid Services (CMS) released the long-awaited Sunshine Act regulations. The Sunshine Act requires disclosure of payments and value transfers (Payments) from drug and...more